BinaxNOW Rapid Antigen Tests for COVID-19 for EMS Agencies

As of 10/9/2020, EMS Agencies in Georgia have the opportunity to request an allocation of BinaxNOW Rapid Antigen Tests for COVID-19. These tests are provided by the U.S. Department of Health and Human Services and are allocated by the Georgia Department of Public Health. 

Please refer to this CDC Interim Guidance for Antigen Testing for SARS-CoV-2.

To qualify for allocation of these test kits, EMS Agencies must:

Any agency requesting allocations of these test kits should prepare by attending these 3 types of trainings, and should review ALL of the information on this page: https://www.globalpointofcare.abbott/en/support/product-installation-training/navica-brand/navica-binaxnow-ag-training.html

This is the recorded training for the Data Reporting Requirements:

Key points regarding the BinaxNOW test kits and CLIA Waivers:

  • If these BinaxNOW tests are allocated to your agency, they are to be used to test symptomatic EMS Agency staff and medics, NOT the general public and NOT patients.
    • These test kits are meant to test symptomatic individuals within the first 7 days of being symptomatic - they are not meant for routine screening of asymptomatic persons.
  • Any agency that receives these kits will be required to report ALL results of the tests (positive, negative, inconclusive) to DPH.
  • You must have a CURRENT CLIA Certificate of Waiver in order to have tests allocated to your agency. Start the process now - see information here:
  • In fact, ALL EMS Agencies need to have a CLIA Certificate - keep in mind that this is not a new requirement, since ALL EMS Agencies have the ability to test blood glucose.